Mark Murcko serves as Executive at Relay Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Mark Murcko has executed 4 insider transactions totaling $1.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 8, 2022 involved selling 25,000 shares valued at $748.8K.
Mark Murcko currently holds 996,952 shares of Relay Therapeutics, Inc. (RLAY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Murcko has been a net seller of RLAY stock. They have purchased $500.0K and sold $748.8K worth of shares.
Mark Murcko's most recent insider trade was on Sep 8, 2022, when they sold 25,000 shares at $29.95 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 20, 2020 | RLAY | $500.0K | Purchase | 25,000 | $20.00 | Discretionary |
| Jul 20, 2020 | RLAY | $0 | Conversion | 281,617 | $N/A | Discretionary |